QIAGEN acquires CLC bio - MarketLine Financial Deals

QIAGEN acquires CLC bio

QIAGEN acquires CLC bio - MarketLine Financial Deals
QIAGEN acquires CLC bio
Published Oct 29, 2013
2 pages — Published Oct 29, 2013
Price US$ 20.00  |  Buy this Report Now

About This Report


QIAGEN N.V., a Netherlands-based holding company that provides sample and assay technologies used to transform biological materials into molecular information, has acquired CLC bio.

Document ID
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author

Cite this Report

MarketLine Financial Deals. "QIAGEN acquires CLC bio" Oct 29, 2013. Alacra Store. Apr 20, 2018. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/QIAGEN-acquires-CLC-bio-2052-105150>
MarketLine Financial Deals. (2013). QIAGEN acquires CLC bio Oct 29, 2013. New York, NY: Alacra Store. Retrieved Apr 20, 2018 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/QIAGEN-acquires-CLC-bio-2052-105150>
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.